1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours

Technology appraisal guidance [TA539] Published date: 29 August 2018

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Documents

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 232.79 KB 29 August 2018  

Final appraisal determination

  • Final appraisal determination  
  • Final appraisal determination document PDF 351.23 KB 20 July 2018  
  • Committee papers PDF 17.11 MB 20 July 2018  
  • Public committee slides PDF 974.56 KB 20 July 2018  
  • Public committee slides PDF 348.19 KB 20 July 2018  

Appraisal consultation

  • Appraisal consultation  
  • Appraisal consultation document PDF 354.28 KB 03 August 2017  
  • Committee papers PDF 13.17 MB 03 August 2017  
  • Public committee slides PDF 897.2 KB 03 August 2017  
  • Public committee slides PDF 446.9 KB 03 August 2017  

Invitation to participate

  • Final scope PDF 111.82 KB 14 June 2017  
  • Final matrix PDF 100.83 KB 14 June 2017  
  • NICE's response to comments on the draft scope and provisional matrix PDF 577.59 KB 14 June 2017  
  • Final protocol PDF 350.65 KB 14 June 2017